Vitiligo Treatment Market Share

Vitiligo Treatment Market Share Analysis

Vitiligo is a long-lasting condition that results in certain areas of the skin losing color or pigment. This happens when melanocytes, which are responsible for skin color, are attacked and destroyed, leading to the appearance of milky-white patches on the skin. Vitiligo affects approximately 0.2% to 1% of the world's population and can occur anywhere on the body where the skin lacks color due to the loss of melanin. The risk of developing vitiligo is higher for individuals with a specific vitiligo gene, those who have experienced sunburns, and those exposed to certain chemicals or mechanical traumas. People with autoimmune conditions like alopecia areata or Hashimoto's are also more prone to developing vitiligo.

The global vitiligo treatment market is categorized based on type into segmental vitiligo and non-segmental vitiligo. In 2021, the non-segmental vitiligo segment held the largest market share, and the segmental vitiligo segment is expected to grow rapidly during the forecast period.

There are organizations such as The Vitiligo Society, American Academy of Dermatology, Vitiligo Research Foundation, Autoimmune Association, Brazilian Society of Dermatology, British Association of Dermatologists, New Zealand Dermatological Society, Australasian Society of Cosmetic Dermatologist, Asian Academy of Dermatology and Venereology, Canadian Dermatology Association, Canadian Dermatology Foundation, Japanese Dermatological Association, European Society for Dermatological Research, and various journals, expert interviews, annual reports, white papers, company presentations, and analyses by MRFR that contribute to the understanding and treatment of vitiligo.

Segmental vitiligo, also known as unilateral or localized vitiligo, is less common and appears asymmetrically on a person's body, causing unpigmented or discolored skin on one part. This type is more prevalent in children, affecting around three in ten children who already have vitiligo. People with vitiligo also become more sensitive to the sun's UV rays, making their skin more prone to sunburn or discomfort. Currently, there is no cure for vitiligo, but various treatments can improve its appearance, including the use of sunscreen, UVB and UVA phototherapy, and topical corticosteroids.

Non-segmental vitiligo, the most common type, results in skin patches appearing all over the body as the skin loses color. When white patches are symmetrical rather than non-symmetrical, it is likely non-segmental vitiligo. This type affects 0.5% to 2% of the global population, and 90% of the time, it is non-segmental. Treatments for non-segmental vitiligo can vary significantly based on patient preferences and the severity of the condition. The global vitiligo treatment market is driven by the continuous efforts of researchers and organizations to develop new and improved treatments for this condition, ultimately contributing to the well-being of those affected by vitiligo.